Hepatitis C virus (HCV) is a global public health problem in correctional settings. The
International Network on Health and Hepatitis in Substance Users–Prisons Network is a …

Background Limited empirical evidence exists for the effectiveness of hepatitis C virus (HCV)
treatment-as-prevention. The Surveillance and Treatment of Prisoners with hepatitis C …

Background & Aims Prisons are key venues for scaling-up hepatitis C virus (HCV) testing
and treatment. Complex clinical pathways and frequent movements of people in prison …

Globally, people living with the Human Immunodeficiency Virus (HIV) are over-represented
in incarcerated populations. The current study aimed to provide a national (Australian) …

Introduction Prison settings represent the highest concentration of prevalent hepatitis C
cases in Australia due to the high rates of incarceration among people who inject drugs …

Following the availability of highly effective direct-acting antivirals (DAAs) to treat hepatitis C
infection, the uptake of treatment by people living with hepatitis C rose dramatically in high …

Background and aims Australia is currently on track to meet the World Health Organization
(WHO) global hepatitis C virus (HCV) elimination goals by 2030, reflecting universal …

In Australian prisons approximately 20% of inmates are chronically infected with hepatitis C
virus (HCV), providing an important population for targeted treatment and prevention. A …

Background Australia's prisons have a high chronic hepatitis C (HCV) prevalence (8%).
Antiviral therapies and prison-based hepatitis services are available, but only a minority of …

Background High patient turnover presents challenges and opportunity to provide hepatitis
C virus (HCV) care in US jails (remand facilities). This study describes the HCV care …